Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers
NCT03291899
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
OTHER
Sponsor class
Stopped
poor accrual
Conditions
Biliary Tract Cancer
Interventions
COMBINATION_PRODUCT:
FOLFIRINOX
Sponsor
King Faisal Specialist Hospital & Research Center